Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2007
08/09/2007WO2006108424A9 Beta-2 adrenoceptor agonists for treating connective tissue diseases of the skin
08/09/2007WO2006104892A3 Morinda citrifolia based antifungal formulations and methods
08/09/2007WO2006086634A3 Oxime and hydroxylamine substituted imidazo[4,5-c] ring compounds and methods
08/09/2007WO2006081555A3 Methods of diagnosis and treatment for asthma, allergic rhinitis and other respiratory diseases based on haplotype association
08/09/2007WO2006081293A8 Delivery of bio-available compounds with anhydrous topical preparations
08/09/2007WO2006072600A8 Androstane 17-alpha-carbonate for use in the treatment of inflammatory and allergic conditions
08/09/2007WO2006071342A3 Cardiovascular compositions
08/09/2007WO2006069754A9 Use of cgrp antagonists in treatment and prevention of hot flushes in prostate cancer patients
08/09/2007WO2006068687A3 Inhibition of hair growth with rnai targeting desmoglein a and nude mrnas
08/09/2007WO2006065601A3 Inhibitors of akt activity
08/09/2007WO2006034402A3 Compounds for inflammation and immune-related uses
08/09/2007WO2006031606A3 Carboxamide spirolactam cgrp receptor antagonists
08/09/2007WO2005123725A9 Novel compound having lipase inhibitory activity
08/09/2007WO2005107779A3 Weight loss composition and method of inducing weight loss
08/09/2007WO2004082612A3 Liposomal formulations and methods of use
08/09/2007WO2004069795A3 Diagnosis and treatment of chronic tissue damage
08/09/2007WO2004063331A3 SiRNA MEDIATED POST-TRANSRIPTIONAL GENE SILENCING OF GENES INVOLVED IN ALOPECIA
08/09/2007US20070186291 for screening assays and generating dominant-negative forms of bacterial toxins; genetic engineering; rapid and efficient
08/09/2007US20070185570 Material for aneurysm curing
08/09/2007US20070185350 freeze-drying; microbiocides; for food preparation equipment, sports equipment
08/09/2007US20070185326 Heterocyclic compound
08/09/2007US20070185324 Nitrogen-containing bicyclic heteroaryl compounds and methods of use
08/09/2007US20070185218 Controlled release formulation for oral administration of metformin
08/09/2007US20070185217 Propofol analogs, process for their preparation, and methods of use
08/09/2007US20070185216 Antiviral method
08/09/2007US20070185215 Pharmaceutical composition containing obovatol as an active ingredient for the prevention and treatment of neurodegenerative diseases
08/09/2007US20070185214 Process of obtaining type II dehydroquinase enzyme inhibitors and precursors thereof
08/09/2007US20070185213 Synergistic anti-inflammatory pharmaceutical compositions and related methods using curcuminoids or methylxanthines
08/09/2007US20070185212 Substituted amino compounds as 5-HT/NA uptake inhibitors
08/09/2007US20070185211 stable new polymorphic forms with controlled free flowing and rate of dissolution in aqueous fluid; dissolving in Chloroform, admixing n-Heptane, maintaining for at least 8 hours and recovering the precipitates; SENSIPAR" for treatment of hyperparathyroidism in patients with chronic kidney disease
08/09/2007US20070185210 Compositions and Methods for Promoting Fat Loss
08/09/2007US20070185209 Treatment methods using triaryl methane compounds
08/09/2007US20070185208 gelling agent having a high ability of gelling an oily base which is capable of giving a gel composition having a strong gel strength and a good transparency, a gel composition having a strong gel strength and a good transparency, an external composition having a good feel upon use, a cosmetic
08/09/2007US20070185207 Indol-7 sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators
08/09/2007US20070185206 Hydrolysis of benzyl 7-[(1R,2R,3R)-2-(4,4-difluoro-3-oxooctyl)-5-oxo-3-(2-tetrahydropyranyloxy) cyclopentyl]heptanoate in the presence of a phosphoric acid compound
08/09/2007US20070185205 Airway Alkalinization as Therapy for Airway Diseases
08/09/2007US20070185204 Crystalline forms of 3-biphenyl-4-yl-(2S)-[(4'-trifluoromethyl-biphenyl-4-carbonyl)-amino]-propionic acid, and methods of use
08/09/2007US20070185203 Treating or preventing vascular condition in patient by administering locally a therapeutically effective amount of a composition that increases metabolic production of nitric oxide by nitric oxide synthases; treatment of glaucoma, pulmonary hypertension, asthma, chronic obstructive pulmonary disease
08/09/2007US20070185202 Methods and compositions for ophthalmic treatment of fungal and bacterial infections
08/09/2007US20070185201 Compositions and Methods for Preventing or Treating Inflammatory Bowel Disease
08/09/2007US20070185200 Screen for pre-eclampsia
08/09/2007US20070185199 Pharmaceutical formulations
08/09/2007US20070185198 Orally administering ethyl icosapentate (epadel) to a patient that has had a stroke at a dose of 0.3 to 6.0 g/day in combination with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor
08/09/2007US20070185197 Phenol derivative, medicinal composition containing the same, and medicinal use thereof
08/09/2007US20070185196 4-phenylsulfanyl-phenylamine derivatives used as BH3 Interacting Domain Death Antagonist (BID), for the treatment of neurodegenerative diseases, liver inflammation, multiple sclerosis, heart disease, ischemic injury and for controlling apoptotic cascade
08/09/2007US20070185195 Hyperuricemia; uricosuric agents, which have potent uricosuric effect and do not cause grave hepatic disorder; against the uptake of uric acid in kidney
08/09/2007US20070185194 Stable oral compositions of azithromycin monohydrate
08/09/2007US20070185193 Huvastatin and its preparation and formulation comprising the huvastatin
08/09/2007US20070185192 Forming duloxetine, or salt thereof; serotonine receptor antagonist
08/09/2007US20070185191 Hydrazide derivatives as prostaglandin receptors modulators
08/09/2007US20070185190 administering a formulation comprising 2-oxo-1-pyrrolidineacetamide (piracetam) as an active ingredient and a pharmaceutically acceptable carrier for treating aphasia stage when no expectation of improvement in symptoms after at least 3 years of language rehabilitation
08/09/2007US20070185189 Prolinylarylacetamides
08/09/2007US20070185188 Bladder cancer treatment and methods
08/09/2007US20070185187 Indazolecarboxamide derivatives for the treatment and prevention of malaria
08/09/2007US20070185186 Compositions for the delivery of substituted napthyl indole derivatives and methods of their use
08/09/2007US20070185185 Derivatives of thienopyrrole as gnrh antagonists
08/09/2007US20070185184 Carbazole derivatives
08/09/2007US20070185182 5-Chloro-6-fluoro-1H-indole-7-carboxylic acid [2-(3-trifluoromethoxy-phenyl)-ethyl]-(4-trimethylsilanyl-benzyl)-amide; inhibitors of the cholesteryl ester transfer protein
08/09/2007US20070185181 Treatment or prevention of hypotension and shock
08/09/2007US20070185180 Pharmaceutical formulation containing phenytoin sodium and magnesium stearate
08/09/2007US20070185179 New compounds
08/09/2007US20070185178 Triazole compounds and their use as metabotropic glutamate receptor antagonists
08/09/2007US20070185177 crystal structure; bioavailability
08/09/2007US20070185176 Heparanase inhibitors and uses thereof
08/09/2007US20070185175 Benzothiazole and azabenzothiazole compounds useful as kinase inhibitors
08/09/2007US20070185174 Use of thiazole derivatives for preparing a medicament intended to protect the mitochondria
08/09/2007US20070185173 Process for the Preparation of the Salts of 4-(Benzimidazolylmethylamino)-Benzamides
08/09/2007US20070185172 Organic compounds
08/09/2007US20070185170 1,1'-(benzene-1,3-diylmethylene)bis[4-(4-chloro-N-methylanilino)pyridinium]dibromide, that inhibit phosphorylcholine biosynthesis by selective blocking of the choline kinase enzyme in tumor cells or in cells affected by parasitic infections; anticarcinogenic or antitumor agents; fungicides; viricides
08/09/2007US20070185169 2-Mercapto-4,5-Diarylimidazole Derivatives and the use thereof as Cyclooxygenase Inhibitors
08/09/2007US20070185168 Piperidine derivatives
08/09/2007US20070185167 Sodium salts of 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione
08/09/2007US20070185166 1-( beta -D-glucopyranuronosyl)-3-[({4-chloro-3-[5-chloro-1-(2, 4-dimethoxybenzyl)-3-methyl-2-oxo-2,3-dihydro-1H-indol-3-yl]benzoyl}(ethyl)amino)methyl]pyridinium chloride; ligands of oxytocin receptors; cream for topical use; control lypolysis, the storage of fat and cellulitus
08/09/2007US20070185165 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
08/09/2007US20070185164 Process for producing an aromatic carbonate
08/09/2007US20070185163 Imidazol derivatives of piperidine as histamine antagonists
08/09/2007US20070185162 Substituted diketopiperazines as oxytocin receptor antagonists
08/09/2007US20070185161 N-[3-(1-Ethyl-5-fluoro-indan-1-yl)-1H-indol-7-yl]-methanesulfonamide; for treating congestive heart disease, hypertension, and atherosclerosis
08/09/2007US20070185160 1-(2H)-isoquinolone derivative
08/09/2007US20070185159 Novel Nitrogen-Containing Heteroaryl Compounds And Methods of Use Thereof
08/09/2007US20070185158 Indol-4 sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators
08/09/2007US20070185157 Tropane derivatives useful in therapy
08/09/2007US20070185156 3-exo-(5-chlorobiphenyl-3-yloxy)-8-azabicyclo[3.2.1]octane; exo 5-(8-azabicyclo[3.2.1]oct-3-yloxy)biphenyl-3-carbonitrile; depression, pain
08/09/2007US20070185155 1-(2-{[(3-fluorophenyl)methyl]oxy}ethyl)-4-[hydroxy(diphenyl)methyl]-1-azoniabicyclo[2.2.2]octane bromide; muscle relaxants, respiratory system disorders; asthma, bronchitis, chronic obstructive lung disease, chronic bronchitis, chronic respiratory obstruction, pulmonary fibrosis, pulmonary fibrosis
08/09/2007US20070185154 1H-pyrrolo[2,3-c]pyridine-7-carboxylic acid (4-tert-butyl-benzyl)-[2-(4-fluoro-3-trifluoromethyl-phenyl)-ethyl]-amide; cardiovascular diseases such as atherosclerosis, peripheral vascular disease, dyslipidemia, hyperbetalipoproteinemia, hypoalphalipoproteinemia, hypercholesterolemia, hypertriglyceridemi
08/09/2007US20070185153 Compounds
08/09/2007US20070185152 Inhibitors of akt activity
08/09/2007US20070185151 Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane NMDA, 5HT3 and neuronal nicotinic receptor antagonists
08/09/2007US20070185150 Therapeutic methods
08/09/2007US20070185149 Novel amido-substituted hydroxy-6-phenylphenanthridines and their use as pde4 inhibtors
08/09/2007US20070185148 M3 muscarinic acetylchoine receptor antagonists
08/09/2007US20070185147 Opioids for the treatment of the restless leg syndrome
08/09/2007US20070185146 Opioids for the treatment of the chronic obstructive pulmonary disease (copd)
08/09/2007US20070185145 Pharmaceutical composition containing a central opioid agonist, a central opioid antagonist, and a peripheral opioid antagonist, and method for making the same
08/09/2007US20070185144 N-((1S,2R)-2-hydroxy-1-(phenylmethyl)-3-(((4S)-2,6,6-trimethyl-4,5,6,7-tetrahydro-1-benzofuran-4yl)amino)propyl)acetamide, used for the treatment of Alzheimer's disease and conditions involving amyloid deposits on the brain
08/09/2007US20070185143 Anticarcinogenic agents, antimetastasis agents; angiogenesis inhibitors; transplant rejection
08/09/2007US20070185142 Process for producing substituted aminoquinazolinone derivative, intermediate therefor, and pest control agent
08/09/2007US20070185141 Thiamine composition for enhancement of physical and mental energy, and related method
08/09/2007US20070185140 Novel purine derivatives, method for preparing them, their application as medicinal products, pharmaceutical compositions and novel use
08/09/2007US20070185139 Thiazolopyrimidine kinase inhibitors
1 ... 3632 3633 3634 3635 3636 3637 3638 3639 3640 3641 3642 3643 3644 3645 3646 3647 3648 3649 3650 3651 3652 ... 7860